Abstract
This study aimed to explore the potential causal relationship between frailty and allergic diseases through bidirectional Mendelian randomization (MR) analysis. Single-nucleotide polymorphisms (SNPs) were selected as instrumental variables from the genome-wide association studies summary data. The inverse variance weighted (IVW) method was used as the main analysis method, and the MR-Egger regression and weighted median method were employed to complement the IVW results. Verification of the reliability of results using multiple sensitivity analysis methods. The results of forward MR analysis revealed a statistically significant positive causal relationship between allergic asthma (AA) and frailty, as well as between atopic dermatitis (AD) and frailty; however, no causal effects were detected between allergic conjunctivitis (AC), allergic rhinitis (AR), and frailty. The results of reverse MR analysis indicated that frailty had a statistically significant positive causal effect on AD and AR, but no causal effect on AA or AC. The sensitivity analysis showed that the MR results were stable, with no heterogeneity and horizontal pleiotropy. This study found a bidirectional causal relationship between AD and frailty, a positive causal relationship between AA and frailty, an inverse causal relationship between AR and frailty, and no causal relationship between AC and frailty. In view of this, it may be recommended to promote routine frailty screening among patients with AD and AR to help identify high-risk individuals early. In addition, appropriate interventions for frailty are crucial to reduce the risk of AA and AD.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
